Pharmacists in East Providence, Rhode Island


29 Pharmacists found in East Providence
male pharmacist

Mr. Joseph Delsesto, RPH


Pharmacist
600 Warren Ave, East Providence, RI 02914
401-438-9501     401-438-9507

female pharmacist

Kerri Daw, PHARMD


Pharmacist
1925 Pawtucket Ave, East Providence, RI 02914
401-431-0450    

male pharmacist

Mark Daniel Trindade, PHARMD


Pharmacist
900 Warren Ave, Suite 301, East Providence, RI 02914
401-330-2480     401-808-6329



male pharmacist

Matthew Jon Poyant, RPH


Pharmacist
655 Warren Ave, East Providence, RI 02914
401-434-5700    

male pharmacist

Michael Caetano


Pharmacist
640 Warren Ave, East Providence, RI 02914
401-438-2272    

female pharmacist

Nicole M Schwab, PHARMD



950 Warren Ave Fl 2, East Providence, RI 02914
401-606-1004    

female pharmacist

Revathi Wims


Pharmacist
640 Warren Ave, East Providence, RI 02914
401-438-2272    

female pharmacist

Robin H Carey, RPH, PHARMD


Pharmacist
950 Warren Ave, East Providence, RI 02914
401-606-1004    

male pharmacist

Scott Robert Kollar


Pharmacist
655 Warren Ave, Rite Aid #10256, East Providence, RI 02914
401-434-5700     401-438-5639

female pharmacist

Stephanie Sayaf, PHARMD


Pharmacist
640 Warren Ave, East Providence, RI 02914
401-438-2272    

male pharmacist

Dr. Thomas Matthew Guarino, PHARMD


Pharmacist
640 Warren Ave, East Providence, RI 02914
401-438-2272    

female pharmacist

Weiqiong Ma, RPH


Pharmacist
655 Warren Ave, East Providence, RI 02914
401-434-5700     401-438-5639

male pharmacist

William K Haddad, RPH


Pharmacist
640 Warren Ave, East Providence, RI 02914
401-438-2272    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.